Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Ambati J, Magagnoli J, Leung H, Wang, Shao-bin, Andrews CA, Fu D, et al. Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. Nature Communications. 2020;11(1). doi:10.1038/s41467-020-18528-z.
Documents & Media
Details
- Authors
- Ambati, Jayakrishna; Magagnoli, Joseph; Leung, Hannah; Wang, Shao-bin; Andrews, Chris A.; Fu, Dongxu; Pandey, Akshat; Sahu, Srabani; Narendran, Siddharth; Hirahara, Shuichiro; Fukuda, Shinichi; Sun, Jian; Pandya, Lekha; Ambati, Meenakshi; Pereira, Felipe; Varshney, Akhil; Cummings, Tammy; Hardin, James W.; Edun, Babatunde; Bennett, Charles L.; Ambati, Kameshwari; Fowler, Benjamin J.; Kerur, Nagaraj; Röver, Christian ; Leitinger, Norbert; Werner, Brian C.; Stein, Joshua D.; Sutton, S. Scott; Gelfand, Bradley D.
- Issue Date
- 2020
- Journal
- Nature Communications
- eISSN
- 2041-1723
- Language
- English
